Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Background The best treatment option for patients with type 2 diabetes in whom treatment with metformin alone fails to achieve adequate glycaemic control is debated. We aimed to compare the long-term effects of pioglitazone versus sulfonylureas, given in addition to metformin, on cardiovascular events in patients with type 2 diabetes. Methods TOSCA.IT was a multicentre, randomised, pragmatic clinical trial, in which patients aged 50-75 years with type 2 diabetes inadequately controlled with metformin monotherapy (2-3 g per day) were recruited from 57 diabetes clinics in Italy. Patients were randomly assigned (1:1), by permuted blocks randomisation (block size 10), stratified by site and previous cardiovascular events, to add-on pioglitazone (15-45 mg) or a sulfonylurea (5-15 mg glibenclamide, 2-6 mg glimepiride, or 30-120 mg gliclazide, in accordance with local practice). The trial was unblinded, but event adjudicators were unaware of treatment assignment. The primary outcome, assessed with a Cox proportional-hazards model, was a composite of first occurrence of all-cause death, non-fatal myocardial infarction, non-fatal stroke, or urgent coronary revascularisation, assessed in the modified intention-to-treat population (all randomly assigned participants with baseline data available and without any protocol violations in relation to inclusion or exclusion criteria). This study is registered with ClinicalTrials.gov, number NCT00700856. Findings Between Sept 18, 2008, and Jan…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The incidence of cardiovascular events was comparable in those treated with a sulfonylurea or pioglitazone in the Thiazolidinediones or Sulfonylureas and Cardiovascular Accidents Intervention Trial (TOSCA.IT) (193), and no difference in the incidence of MACE was found in people at high cardiovascular risk treated with glimepiride or linagliptin (194), a medication whose cardiovascular safety was”
In the citing paper
“although sulfonylureas have been associated with increased cardiovascular mortality in retrospective observational studies, most large controlled clinical trials have generally proved sulfonylureas (particularly second-generation agents) to be safe and cardiovascular neutral”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [203]
Citations
Cites
Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence
Singer, J. D., & Willett, J. B. (2003) · doi:10.1093/acprof:oso/9780195152968.001.0001 · Cited by 10,647
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
“IT) [193], and no difference in the incidence of MACE was found in people at high cardiovascular risk treated with glimepiride or linagliptin [194], a medication whose cardiovascular safety was demonstrated in a population at high cardiovascular and renal risk [195].”
Metadata
- Authors
- Vaccaro, O., Masulli, M., Nicolucci, A., Bonora, E., Del Prato, S., Maggioni, A. P., Rivellese, A. A., Squatrito, S., Giorda, C. B., Sesti, G., Mocarelli, P., Lucisano, G., Sacco, M., Signorini, S., Cappellini, F., Perriello, G., Babini, A. C., Lapolla, A., Gregori, G., Giordano, C., Corsi, L., Buzzetti, R., Clemente, G., Di Cianni, G., Iannarelli, R., Cordera, R., La Macchia, O., Zamboni, C., Scaranna, C., Boemi, M., Iovine, C., Lauro, D., Leotta, S., Dall'Aglio, E., Cannarsa, E., Tonutti, L., Pugliese, G., Bossi, A. C., Anichini, R., Dotta, F., Di Benedetto, A., Citro, G., Antenucci, D., Ricci, L., Giorgino, F., Santini, C., Gnasso, A., De Cosmo, S., Zavaroni, D., Vedovato, M., Consoli, A., Calabrese, M., di Bartolo, P., Fornengo, P., Riccardi, G., Vaccaro, O., Masulli, M., Nicolucci, A., Maggioni, A. P., Sesti, G., Mocarelli, P., Lucisano, G., Sacco, M., Signorini, S., Cappellini, F., Riccardi, G., Boemi, M., D'Angelo, F., Giansanti, R., Tanase, L., Lanari, L., Testa, I., Ricci, L., Pancani, F., Ranchelli, A., Vagheggi, P., Scatona, A., Fontana, L., Giorgino, F., Laviola, L., Tarantino, L., Ippolito, C., Gigantelli, V., Manicone, M., Conte, E., Trevisan, R., Scaranna, C., Rota, R., Corsi, A., Dodesini, A. R., Reggiani, G. M., Montesi, L., Mazzella, N., Forlani, G., Caselli, C., Di Luzio, R., Mazzotti, A., Aiello, A., Barrea, A., Musto, A., D'Amico, F., Squatrito, S., Sinagra, T., Longhitano, S., Trowpea, V., Sparti, M., Italia, S., Lisi, E., Grasso, G., Pezzino, V., Insalaco, F., Gnasso, A., Carallo, C., Scicchitano, C., De Franceschi, M. S., Santini, C., Mazzotti, A., Caselli, C., Calbucci, G., Ripani, R., Corsi, L., Cuneo, G., Corsi, S., Giorda, C. B., Romeo, F., Lesina, A., Comoglio, M., Bonetto, C., Robusto, A., Nada, E., Asprino, V., Cetraro, R., Impieri, M., Lucchese, G., Donnarumma, G., Tizio, B., Clemente, G., Lenza, L., Paraggio, P., Tomasi, F., Zamboni, C., Dozio, N., Scalambra, E., Mannucci, E., Lamanna, C., Cignarelli, M., Macchia, O. L., Fariello, S., Sorrentino, M. R., Franzetti, I., Radin, R., Cordera, R., Annunziata, F., Bonabello, L. A., Durante, A., Dolcino, M., Gallo, F., Mazzucchelli, C., Aleo, A., Melga, P., Briatore, L., Maggi, D., Storace, D., Cecoli, F., Antenucci, D., D'Ugo, E., Pupillo, M., Baldassarre, M. P. A., Salvati, F., Minnucci, A., De Luca, A., Zugaro, A., Santarelli, L., Bosco, A., Petrella, V., La Verghetta, G. G., Iannarelli, R., De Gregorio, A., D'Andrea, S., Giuliani, A. E., Polidoro, W. L., Sperandio, A., Sciarretta, F., Pezzella, A., Buzzetti, R., Carlone, A., Potenziani, S., Venditti, C., Foffi, C., Carbone, S., Cipolloni, L., Moretti, C., Leto, G., Serra, R., Petrachi, F., Romano, I., Di Cianni, G., Lacaria, E., Russo, L., Goretti, C., Sannino, C., Gregori, G., Dolci, M., Bruselli, L., Mori, M. L., Baccetti, F., Del Freo, M., Fontana, L., Di Benedetto, A., Cucinotta, D., Giunta, L., Ruffo, M. C., Cannizzaro, D., Pintaudi, B., Perrone, G., Pata, P., Ragonese, F., Lettina, G., Mancuso, T., Coppolino, A., Piatti, P. M., Monti, L., Stuccillo, M., Lucotti, P., Setola, M., Crippa, G. V., Loi, C., Oldani, M., Bottalico, M. L., Pellegata, B., Bonomo, M., Menicatti, L. S. M., Resi, V., Bertuzzi, F., Disoteo, E. O., Pizzi, G., Rivellese, A. A., Annuzzi, G., Capaldo, B., Nappo, R., Auciello, S. M., Turco, A. A., Costagliola, L., Iovine, C., Corte, G. D., Vallefuoco, P., Nappi, F., Vitale, M., Cocozza, S., Ciano, O., Massimino, E., Garofalo, N., Avogaro, A., Vedovato, M., Guarneri, G., Lapolla, A., Fedele, D., Sartore, G., Chilelli, N. C., Burlina, S., Bonsembiante, B., Giordano, C., Galluzzo, A., Torregrossa, V., Dall'Aglio, E., Mancastroppa, G., Arsenio, L., Cioni, F., Caronna, S., Papi, M., Babini, M., Perriello, G., Santeusanio, F., Calagreti, G., Timi, A., Tantucci, A., Marino, C., Consoli, A., Ginestra, F., Di Biagio, R., Taraborelli, M., Del Prato, S., Miccoli, R., Bianchi, C., Garofolo, M., Politi, K. S., Penno, G., Zavaroni, D., Livraga, S., Calzoni, F., Mancastroppa, G. L. F., Anichini, R., Corsini, E., Tedeschi, A., Gaglianò, M. S., Ippolito, G., Salutini, E., Citro, G., Cervellino, F., Natale, M., Salvatore, V., Zampino, A., Sinisi, R., Calabrese, M., Arcangeli, A., Zogheri, A., Guizzotti, S., Longo, R., Di Bartolo, P., Caselli, C., Pellicano, F., Scolozzi, P., Termine, S., Luberto, A., Ballardini, G., Babini, A. C., Ripani, R., Trojani, C., Mazzuca, P., Bruglia, M., Ciamei, M., Genghini, S., Zannoni, C., Pugliese, G., Vitale, M., Rangel, G., Salvi, L., Zappaterreno, A., Cordone, S., Simonelli, P., Meggiorini, M., Frasheri, A., Di Pippo, C., Maglio, C., Mazzitelli, G., Lauro, D., Rinaldi, M. E., Galli, A., Romano, M., D'Angelo, P., Leotta, S., Suraci, C., De Cosmo, S., Bacci, S., Palena, A. P., Genovese, S., Mancino, M., Rondinelli, M., Capone, F., Calabretto, E., Bulgheroni, M., Bucciarelli, L., Dotta, F., Ceccarelli, E., Fondelli, C., Santacroce, C., Guarino, E., Nigi, L., Lalli, C., Di Vizia, G., Scarponi, M., Montani, V., Di Bernardino, P., Romagni, P., Dolcetti, K., Cannarsa, E., Forte, E., Potenziani, S., Tamburo, L., Fornengo, P., Perin, P. C., Prinzis, T., Gruden, G., Bruno, G., Zucco, C., Perotta, M., Marena, S., Monsignore, S., Panero, F., Ponzi, F., Bossi, A. C., Carpinteri, R., Casagrande, M. L., Coletti, M. F., Menicatti, L. S. M., Balini, A., Filopanti, M., Madaschi, S., Pulcina, A., Grimaldi, F., Tonutti, L., Venturini, G., Agus, S., Pagnutti, S., Guidotti, F., Cavarape, A., Casagrande, M. L., Bonora, E., Cigolini, M., Pichiri, I., Brangani, C., Fainelli, G., Tomasetto, E., Zoppini, G., Galletti, A., Perrone, D., Capra, C., Bianchini, F., Ceseri, M., Di Nardo, B., Sasso, E., Bartolomei, B., Suliman, I., Fabbri, G., Romano, G., Maturo, N., Nunziata, G., Capobianco, G., De Simone, G., Villa, V., Rota, G., Pentangelo, C., Carbonara, O., Caiazzo, G., Cutolo, M., Sorrentino, T., Mastrilli, V., Amelia, U., Masi, S., Corigliano, G., Gaeta, I., Armentano, V., Calatola, P., Capuano, G., Angiulli, B., Auletta, P., Petraroli, E., Iodice, C. E., & Agrusta, M.
- Affiliations
- Azienda sanitaria universitaria Friuli Centrale (IT)
- University of Turin (IT)
- San Salvatore Hospital (IT)
- Federico II University Hospital (IT)
- Azienda Socio Sanitaria Territoriale di Bergamo Ovest (IT)
- Azienda Usl Toscana Centro (IT)
- Casa Sollievo della Sofferenza (IT)
- University of Bari Aldo Moro (IT)
- University of Parma (IT)
- Azienda USL Toscana Nord Ovest (IT)
- Sapienza University of Rome (IT)
- University of Padua (IT)
- University of Ferrara (IT)
- Associazione Nazionale Medici Cardiologi Ospedalieri (IT)
- Ospedale "Floraspe Renzetti" (IT)
- Ospedale Infermi di Rimini (IT)
- Magna Graecia University (IT)
- Azienda Ospedale - Università Padova (IT)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- Institute for Research on Population and Social Policies (IT)
- Center for Outcomes Research and Clinical Epidemiology (IT)
- Ospedale Sandro Pertini (IT)
- ORCID
- Testa, Ivano
- Laviola, Luigi
- Manicone, Mariangela
- Conte, Eleonora
- Trevisan, Roberto
- Corsi, Anna
- Dodesini, Alessandro R.
- Carallo, Claudio
- Romeo, Francesco
- Nada, Elisa
- Donnarumma, Giovanna
- Tomasi, Franco
- Dozio, Nicoletta
- Mannucci, Edoardo
- Maggi, Davide
- Baldassarre, Maria Pompea Antonia
- Carbone, Salvatore
- Moretti, Chiara
- Leto, Gaetano
- Russo, Laura
- Goretti, Chiara
- Baccetti, Fabio
- Cucinotta, Domenico
- Ruffo, Maria Concetta
- Pintaudi, Basilio
- Coppolino, Aldo
- Monti, Lucilla
- Lucotti, Pietro
- Resi, Veronica
- Bertuzzi, Federico
- Annuzzi, Giovanni
- Capaldo, Brunella
- Corte, Giuseppina Della
- Nappi, Francesca
- Vitale, Marilena
- Avogaro, Angelo
- Sartore, Giovanni
- Chilelli, Nino Cristiano
- Burlina, Silvia
- Bonsembiante, Barbara
- Miccoli, Roberto
- Bianchi, Cristina
- Garofolo, Monia
- Penno, Giuseppe
- Tedeschi, Anna
- Salutini, Elisabetta
- Vitale, Martina
- Maglio, Cristina
- Bacci, Simonetta
- Genovese, Stefano
- Capone, Filippo
- Bucciarelli, Loredana
- Fondelli, Cecilia
- Nigi, Laura
- Gruden, Gabriella
- Bruno, Graziella
- Panero, Francesco
- Filopanti, Marcello
- Grimaldi, Franco
- Guidotti, Francesca
- Cavarape, Alessandro
- Cigolini, Massimo
- Zoppini, Giacomo
- Galletti, Anna
- Corigliano, Gerardo
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 5
- Issue
- 11
- Pages
- 887-897
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W2755083612
- Cited by
- 292
- References
- 30
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 21 · 2023: 32 · 2022: 42 · 2021: 30 · 2020: 46 · 2019: 36 · 2018: 46 · 2017: 9
- FWCI
- 29.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Use Siena air (University of Siena) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Agenzia Italiana del Farmaco, Ministero della Salute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, pioglitazone, sulfonylureas, metformin add-on therapy, cardiovascular events, myocardial infarction, stroke, all-cause mortality, glibenclamide, glimepiride, gliclazide, futility analysis, glycemic control, thiazolidinediones
- MeSH terms
- Pioglitazone, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Sulfonylurea Compounds, Incidence, Treatment Outcome, Thiazolidinediones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. https://app.cochat.ai/papers/10.1016/s2213-8587(17)30317-0
- The paper
- Vaccaro, O., Masulli, M., Nicolucci, A., Bonora, E., Del Prato, S., Maggioni, A. P., Rivellese, A. A., Squatrito, S., Giorda, C. B., Sesti, G., Mocarelli, P., Lucisano, G., Sacco, M., Signorini, S., Cappellini, F., Perriello, G., Babini, A. C., Lapolla, A., Gregori, G., . . . Agrusta, M. (2017). Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(17)30317-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.